This project has been recognised as a **winner** of the 2025 Responsible Care Awards.
Ireland’s biopharmachem sector has long been at the forefront of sustainable innovation. Companies have introduced cutting-edge technologies and processes, but efforts were often fragmented and hard to track. To create cohesion and accelerate impact, BioPharmaChem Ireland (BPCI), the representative body for the sector, launched the Sustainability Strategy and Responsible Care Report 2025, providing a shared framework for sustainable growth across the industry.
From left to right: Joyce Fitzharris, President of SK Pharmteco Small Molecule Europe & Chair of Biopharmachem Ireland – Sinead Keogh, Director BPCI –Michael Kilkelly, Senior Executive EHS BPCI
A shared roadmap for the sector
The initiative moves beyond compliance by embedding environmental, health, safety, and sustainability considerations into daily operations. It identifies four strategic pillars guiding the sector’s efforts:
- Electricity & Infrastructure – optimising energy use and infrastructure investments.
- Scope 3 Emissions – addressing upstream and downstream emissions.
- Data & Standards – standardising metrics and reporting.
- Culture & Communications – fostering a sustainability mindset across organizations.
This structured approach allows companies – from multinational corporations to SMEs – to benchmark progress, share knowledge, and identify critical gaps.
Collaboration and collective impact
BPCI’s strategy emphasises cross-sector collaboration, aligning supply chains and engaging stakeholders at local, national, and EU levels. SMEs, in particular, benefit from access to shared data, guidance, and best practices, helping the entire ecosystem advance together.
By providing a data-driven view of sector-wide progress, the strategy supports regulators and policymakers in designing effective frameworks and directing investments where they matter most. It also strengthens Ireland’s global reputation, positioning the country as a hub for sustainable biopharmachem manufacturing and innovation.